Changes in Pramipexole Utilization after Introduction of the Extended-Release Formulation: A Nationwide Study in Taiwan.

K Arnold ChanYu-Chun HsiehShu-Feng HsiehRou-Shayn Chen

Published in: Drugs - real world outcomes (2020)

Introduction of pramipexole ER to Taiwan resulted in higher LEDD in prescriptions with pramipexole. Patients with Parkinson's disease who were initiated on pramipexole ER had better adherence to the medication than those who were prescribed pramipexole IR.

Keyphrases

healthcare
drug delivery
estrogen receptor
breast cancer cells
emergency department
type diabetes
metabolic syndrome
skeletal muscle
drug induced